Investing News

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Procter & Gamble to cut 7,000 jobs as...

Web Summit 2025: AI Innovation, Investment Shifts and...

Web Summit 2025: AI Innovation, Investment Shifts and...

Crypto Market Recap: Strategy Eyes US$1 Billion Capital...

Crypto Market Recap: Strategy Eyes US$1B Raise for...

US Capital Global Facilitates $50MM Financing to Accelerate...

Justin Huhn: Uranium Game On — Supply “Mirage,”...

Shein and Temu see U.S. demand plunge as...

Should You Invest in Silver Bullion?

Trump Admin Strips “Safety” from AI Oversight Institute...